Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY
– by the National Medical Products Administration of China for the Treatment of Moderately to Severely Active Ulcerative Colitis Everest Medicines (HKEX 1952.HK, Everest, or the Company), a biopharmaceutical company…